Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

New HIV protease inhibitors from Searle

Sep. 13, 1996

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Seratrodast claimed for the treatment of atopic dermatitis

Sep. 13, 1996

Antibacterial agents disclosed by Hokuriku

Sep. 13, 1996

Allergan discloses compounds with retinoid-like activity

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Retinoid compounds for dermatological disorders

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...